| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |